Bridgeway Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $119K | Hold |
|
|||||
|
2024
Q2 | $179K | Hold |
|
|||||
|
2024
Q1 | $167K | Hold |
|
|||||
|
2023
Q4 | $167K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $499K | Hold |
|
|||||
|
2018
Q1 | $348K | Hold |
|
|||||
|
2017
Q4 | $353K | Hold |
|
|||||
|
2017
Q3 | $394K | Hold |
|
|||||
|
2017
Q2 | $521K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1.12M | Sell |
|
|||||
|
2015
Q2 | $2.6M | Buy |
|
|||||
|
2015
Q1 | $1.34M | Hold |
|
|||||
|
2014
Q4 | $496K | Buy |
|
|||||
|
2014
Q3 | $215K | Buy |
|